President Trump’s latest attempt at implementing International Reference Pricing- based (IRP-) methodology to regulate drug prices in the US has the broadest and strictest scope.
Anaïs Frappé
Advertisement
Articles by Anaïs Frappé
Cancer patients’ journeys are complex and the benefit of a drug goes well beyond survival, even in cases of incurable and/or metastatic cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pfizer Receives Unsolicited Mini-Tender Offer for 1 Million Shares from Tutanota: Report
2
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
3
How Do Recent Actions from FDA Provide Insight to the Agency's Enforcement Posture?
4
Pharmaceutical Executive Daily: Pfizer Warns Shareholders to Reject Mini-Tender Offer
5